Primary sclerosing cholangitis: Resect, dilate, or transplant?

Annals of Surgery

Volumn 227, Issue 3, 1998, Pages 412-423

  Ahrendt, Steven A ^a   Pitt, Henry A ^b   Kalloo, Anthony N ^a   Venbrux, Anthony C ^a   Klein, Andrew S ^a   Herlong, H Franklin ^a   Coleman, Joann ^a   Lillemoe, Keith D ^a   Cameron, John L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT SURGERY; CHOLESTASIS; ENDOSCOPIC SURGERY; FEMALE; HUMAN; INFLAMMATORY CELL; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; STENT; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHOLANGITIS, SCLEROSING; DILATATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STENTS; TIME FACTORS;

EID: 0031887849     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199803000-00014     Document Type: Article

References (33)

1. Chapman RWG, Marborgh BA. Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21:870-877.
2. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79:200-206.
3. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 1989; 10:430-436.
4. Porayko MK, Wiesner RH, LaRusso NF, et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98:1594-1602.
5. Cameron JL, Pitt HA, Zinner MJ, et al. Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg 1988; 207:614-622.
6. Pitt HA, Thompson HH, Tompkins RK, Longmire WP. Primary sclerosing cholangitis: results of an aggressive surgical approach. Ann Surg 1982; 196:259-268.
7. Myburgh JA. Surgical biliary drainage in primary sclerosing cholangitis: the role of the Hepp-Couinaud approach. Arch Surg 1994; 129:1057-1062.
8. Lemmer ER, Bornman PC, Krige JEJ, et al. Primary sclerosing cholangitis: requiem for biliary drainage operations? Arch Surg 1994; 129:723-728.
9. Farges O, Malassagne B, Sebaugh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995; 117:146-155.
10. Ismail T, Angrisani L, Powell JE, et al. Primary sclerosing cholangitis: surgical options, prognostic variables, and outcome. Br J Surg 1991; 78:564-567.
11. Mueller PR, van Sonnenberg E, Ferruci JT, et al. Biliary stricture dilatation: multicenter review of clinical management in 73 patients. Radiology 1986; 160:17-22.
12. Johnson GK, Geenan JE, Venu RP, et al. Endoscopie treatment of biliary tract strictures in sclerosing cholangitis: a large series and reccommendations for treatments. Gastrointest Endosc 1991; 37:38-43.
13. Gaing AA, Geders JM, Cohen SA, Siegel JH. Endoscopie management of primary sclerosing cholangitis: review, and report of an open series. Am J Gastroenterol 1993; 88:2000-2008.
14. Lee JG, Schutz SM, England RE, et al. Endoscopie therapy of sclerosing cholangitis. Hepatology 1995; 21:661-667.
15. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149:39-44.
16. Dickson ER, Murtaugh PA, Wiesner RH, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103:1893-1901.
17. Ludwig J, Barham SS, LaRusso NF, et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1:632-640.
18. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
19. Beuers U, Spengler U, Kruis W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a double-blind placebo-controlled trail. Hepatology 1992; 16:707-714.
20. Knox TA, Kaplan MM. Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol 1991; 86:546-552.
21. Abu-Elmagd KM, Malinchoc M, Dickson ER, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177:335-344.
22. Cameron JL, Gayler BW, Sanfey H, et al. Sclerosing cholangitis: anatomical distribution of obstructive lesions. Ann Surg 1984; 200: 54-60.
23. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994; 69:969-982.
24. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332:924-933.
25. Narumi S, Roberts JP, Emond JC, et al. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22:451-957.
26. McEntee G, Wiesner RH, Rosen C, et al. Comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transplant Proc 1991; 23: 1563-1564.
27. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994; 20:356-361.
28. Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213:21-25.
29. Knechtle SJ, D'Alessandro AM, Harms BA, et al. Relationship between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995; 118:615-620.
30. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108:865-869.
31. Nakeeb A, Lipsett PA, Lillemoe KD, et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996; 171:147-153.
32. Abu-Elmagd KM, Selby R, Iwatsuki S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25:1124-1129.
33. Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68:874-879.